Cargando…
Release of VEGF and BMP9 from injectable alginate based composite hydrogel for treatment of myocardial infarction
Myocardial infarction (MI) is one of cardiovascular diseases that pose a serious threat to human health. The pathophysiology of MI is complex and contains several sequential phases including blockage of a coronary artery, necrosis of myocardial cells, inflammation, and myocardial fibrosis. Aiming at...
Autores principales: | Wu, Yong, Chang, Tianqi, Chen, Weiqian, Wang, Xiaoyu, Li, Jingjing, Chen, Yueqiu, Yu, You, Shen, Zhenya, Yu, Qian, Zhang, Yanxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492819/ https://www.ncbi.nlm.nih.gov/pubmed/32995677 http://dx.doi.org/10.1016/j.bioactmat.2020.08.031 |
Ejemplares similares
-
The enhanced effect and underlying mechanisms of mesenchymal stem cells with IL-33 overexpression on myocardial infarction
por: Chen, Yueqiu, et al.
Publicado: (2019) -
Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications
por: Campbell, Kevin T., et al.
Publicado: (2017) -
MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction
por: Chen, Yueqiu, et al.
Publicado: (2017) -
Incorporation of small extracellular vesicles in sodium alginate hydrogel as a novel therapeutic strategy for myocardial infarction
por: Lv, Kaiqi, et al.
Publicado: (2019) -
Engineered Exosomes With Ischemic Myocardium‐Targeting Peptide for Targeted Therapy in Myocardial Infarction
por: Wang, Xu, et al.
Publicado: (2018)